Fundz
Back to Investors

Track Euclidean Capital's Investment Activity

Get real-time alerts when Euclidean Capital makes new investments. Full investor profiles, co-investor networks, and deal history are available on Pro plans.

Compare PlansProFull access from $59/mo
E

Euclidean Capital

Hedge Fund

Family office of the late Jim Simons (1938-2024), legendary mathematician and founder of Renaissance Technologies. Simons was often called "the greatest investor on Wall Street" - his Medallion Fund generated 66% average annual returns (39% after fees) from 1988-2018, producing $104.5 billion in profits. Former NSA codebreaker, Stony Brook math chair, and co-author of Chern-Simons theory. Net worth peaked at $31.4 billion. Founded Euclidean Capital 2009 to manage personal wealth. Led by CIO Ashvin Chhabra (former Merrill Lynch CIO). Focus on AI, biotech, life sciences investments. Also funds Simons Foundation ($4B+ in science philanthropy) and Flatiron Institute computational research.

Total Deals
18
Recent (90d)
0
Total Capital
$1.3B
Co-Investors
86
R

Ripple Foods

Information Technology
$17.0M

Dec 3, 2025

L

Leal Therapeutics

BiotechnologyWorcester, United States
series a
$30.0M

Aug 27, 2025

S

SetPoint Medical

Healthcare
series d
$140.0M

Aug 11, 2025

A

Actio Biosciences

BiotechnologySan Diego, United States
series b
$66.0M

Jun 18, 2025

Z

Zeitview

Software
$60.0M

Mar 5, 2025

13+ more investments

View all 18 deals by Euclidean Capital

ProFull deal history requires Pro

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. Trusted by firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz tracks 200,000+ companies and 40,000+ investors.